These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
350 related items for PubMed ID: 1395845
1. DNA content and its relationship with pathology and prognosis of colorectal carcinoma. Jiang B, Liu CG, Wang MW, Zhao DH, Li Y, Ji XL. Chin Med J (Engl); 1992 Mar; 105(3):241-6. PubMed ID: 1395845 [Abstract] [Full Text] [Related]
2. DNA quantitation by image analysis of paraffin-embedded colorectal adenocarcinomas and its prognostic value. Bosari S, Lee AK, Wiley BD, Heatley GJ, Hamilton WM, Silverman ML. Mod Pathol; 1992 May; 5(3):324-8. PubMed ID: 1495937 [Abstract] [Full Text] [Related]
3. Flow cytometric DNA analysis of poorly differentiated adenocarcinoma of the colorectum. Taniyama K, Suzuki H, Matsumoto M, Hakamada K, Toyama K, Tahara E. Jpn J Clin Oncol; 1991 Dec; 21(6):406-11. PubMed ID: 1805045 [Abstract] [Full Text] [Related]
4. Flow cytometric analysis of DNA abnormalities in colorectal carcinomas. Bocquillon PG, Daver A, Page M, Dalifard I, Chassevent A, Cellier P, Bertrand G, Larra F, George P, Chabrun B. Bull Cancer; 1989 Dec; 76(3):291-300. PubMed ID: 2736315 [Abstract] [Full Text] [Related]
5. Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma. Purdie CA, Piris J. Histopathology; 2000 Feb; 36(2):121-6. PubMed ID: 10672056 [Abstract] [Full Text] [Related]
6. Prognostic significance of DNA ploidy pattern and nucleolar organizer regions (AgNOR) in colorectal carcinoma. Eminović-Behrem S, Trobonjaca Z, Petrovecki M, Dobi-Babić R, Dujmović M, Jonjić N. Croat Med J; 2000 Jun; 41(2):154-8. PubMed ID: 10853043 [Abstract] [Full Text] [Related]
7. Flow cytometric analysis of DNA ploidy and cell proliferation activity in colorectal carcinoma. Mazzei T, Tonelli F, Mini E, Mazzoni P, Pesciullesi A, Valanzano R, Ficari F, Biondi C, Periti P. Anticancer Res; 1995 Jun; 15(5B):2247-53. PubMed ID: 8572632 [Abstract] [Full Text] [Related]
8. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study. Bazan V, Migliavacca M, Zanna I, Tubiolo C, Corsale S, Calò V, Amato A, Cammareri P, Latteri F, Grassi N, Fulfaro F, Porcasi R, Morello V, Nuara RB, Dardanoni G, Salerno S, Valerio MR, Dusonchet L, Gerbino A, Gebbia N, Tomasino RM, Russo A. J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051 [Abstract] [Full Text] [Related]
9. [Flow cytometric DNA analysis of malignant potential in colorectal cancer]. Ando Y, Tsuchiya A, Oki S, Sato H, Yoshida T, Kimijima I, Abe R. Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():112-7. PubMed ID: 8678552 [Abstract] [Full Text] [Related]
10. Histopathologic parameters and DNA analysis in colorectal adenocarcinomas. Crissman JD, Zarbo RJ, Ma CK, Visscher DW. Pathol Annu; 1989 Jun; 24 Pt 2():103-47. PubMed ID: 2671879 [Abstract] [Full Text] [Related]
11. [Flow cytometric analysis in colorectal cancer with hepatic metastases and its relationship to metastatic characteristics and prognosis]. Yamaguchi A, Ishida T, Nishimura G, Kanno M, Kosaka T, Yonemura Y, Miyazaki I. Nihon Geka Gakkai Zasshi; 1990 Oct; 91(10):1591-5. PubMed ID: 2263242 [Abstract] [Full Text] [Related]
12. Prognostic significance of DNA content abnormalities in young patients with colorectal cancer. Heimann TM, Martinelli G, Szporn A, Kurtz RJ, Quish A, Miller F, Oh SC, Fasy T. Ann Surg; 1989 Dec; 210(6):792-5. PubMed ID: 2589893 [Abstract] [Full Text] [Related]
13. Clinical and pathological significance of numerical aberrations of chromosomes 11 and 17 in colorectal neoplasms. Tagawa Y, Yasutake T, Sawai T, Nanashima A, Jibiki M, Morinaga M, Akama F, Nakagoe T, Ayabe H. Clin Cancer Res; 1997 Sep; 3(9):1587-92. PubMed ID: 9815847 [Abstract] [Full Text] [Related]
14. The importance of heterogeneity and of multiple site sampling in the prospective determination of deoxyribonucleic acid flow cytometry. Stipa S, Danesi DT, Modini C, Cicconetti F, Mauro F, Schillaci A, Mecozzi A, Nicolanti V, Stipa F, Mancini M. Surg Gynecol Obstet; 1993 May; 176(5):427-34. PubMed ID: 8386859 [Abstract] [Full Text] [Related]
15. DNA flow cytometry of colorectal carcinoma: correlation of DNA stemlines with other prognostic indices. Bawani M, Tibrewala S, Copur S, Harris D, Gilman-Sachs A. Am J Gastroenterol; 1991 Feb; 86(2):191-5. PubMed ID: 1992633 [Abstract] [Full Text] [Related]
16. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors. Susini T, Amunni G, Molino C, Carriero C, Rapi S, Branconi F, Marchionni M, Taddei G, Scarselli G. Cancer; 2007 Mar 01; 109(5):882-90. PubMed ID: 17262824 [Abstract] [Full Text] [Related]
17. [Prognostic significance of flow cytometric DNA analysis in colorectal cancer]. Ando Y. Nihon Geka Gakkai Zasshi; 1990 Nov 01; 91(11):1700-9. PubMed ID: 2277618 [Abstract] [Full Text] [Related]
18. DNA ploidy analysis of endometrial adenocarcinoma using a flow cytometry from paraffin-embedded tissues. Takahashi Y. Nihon Sanka Fujinka Gakkai Zasshi; 1990 Oct 01; 42(10):1339-44. PubMed ID: 1700035 [Abstract] [Full Text] [Related]
19. Thymidylate synthase level and DNA-ploidy pattern as possible prognostic factors in human colorectal cancer: a preliminary study. Sanguedolce R, Brumarescu I, Dardanoni G, Grassadonia A, Vultaggio G, Rausa L. Anticancer Res; 1995 Oct 01; 15(3):901-6. PubMed ID: 7645979 [Abstract] [Full Text] [Related]
20. [Retrospective flow-cytometric analysis of the DNA content in colorectal carcinomas and the test of the prognostic significance of DNA ploidy]. Baretton G, Gille J, Oevermann E, Löhrs U. Verh Dtsch Ges Pathol; 1990 Oct 01; 74():233-7. PubMed ID: 1708591 [Abstract] [Full Text] [Related] Page: [Next] [New Search]